Global Immunohematology Supply, Demand and Key Producers, 2026-2032
The global Immunohematology market size is expected to reach $ 3495 million by 2032, rising at a market growth of 4.5% CAGR during the forecast period (2026-2032).
Commercially, immunohematology usually refers to pre-transfusion compatibility testing and blood-group serology/molecular typing solutions. The core menu includes ABO/Rh typing, antibody screening, antibody identification, crossmatching, DAT/IAT, antigen typing/extended phenotyping, and selected molecular typing for rare or complex cases. Product formats span gel/cards, reagent red cells, antisera, QC materials, fully/semi-automated analyzers, data-management software, and in some cases reference-laboratory testing services. Upstream inputs include antibodies, reagent RBC materials, plastics/consumables, automation modules, and software; midstream is reagent?instrument system integration; downstream customers are primarily hospital transfusion laboratories/blood banks, independent labs, blood centers, and reference labs.
Immunohematology, as a core interdisciplinary field integrating immunology and hematology, focuses on the interaction between blood components and the immune system, covering key areas such as blood grouping, transfusion safety, diagnosis and treatment of autoimmune hematological diseases, and hematopoietic stem cell transplantation matching. It is an important part of the global healthcare system, and its development is closely linked to multiple global trends, including the upgrading of clinical needs, breakthroughs in technological innovation, and the protection of public health security. The continuous growth of global clinical transfusion demand and the continuous improvement of transfusion safety standards are the core driving forces. The demand for safe blood transfusion in various surgeries, chronic diseases and trauma treatment has promoted the transformation of immunohematology technology towards precision and standardization, reducing the risk of transfusion adverse reactions. The clinical diagnosis and treatment needs of hematological tumors, autoimmune hematological diseases and other diseases have promoted the discipline to extend towards precise immunotherapy and personalized diagnosis and treatment, broadening the research and application boundaries. Technological innovation continues to empower the industry. The application of automated detection platforms, molecular typing technologies, AI-assisted interpretation systems and other technologies has improved detection efficiency and accuracy, promoting the discipline to develop in a diversified and cross-integrated direction. The improvement of the global public health system and the enhancement of blood safety awareness have promoted countries to strengthen blood screening, rare blood type bank construction and standardized construction of immunohematology laboratories. At the same time, the upgrading of medical infrastructure in emerging markets has released new growth for the development of the discipline. The global cooperation between leading enterprises and scientific research institutions has accelerated the global popularization of technological achievements.
Despite the continuous development of the global immunohematology field and the increasing clinical value, it still faces many challenges. High-end technologies and core reagent barriers are strict. The core technologies of precise molecular typing, high-end detection equipment and key reagents are monopolized by a few international leading enterprises. Emerging markets and developing countries have insufficient investment in scientific research, making it difficult to achieve technological breakthroughs and independent substitution, resulting in unbalanced distribution of medical resources. There are regional differences in the development of the discipline. Developed countries, relying on mature medical systems and scientific research strength, focus on cutting-edge technology research and development and clinical application, occupying a dominant position in the industry. However, some developing countries, limited by medical resources and professional talents, have insufficient accessibility of immunohematology detection and diagnosis and treatment services. There is a gap between clinical application and technological transformation. Some cutting-edge technologies have high R&D costs and long certification cycles, making it difficult to quickly land and popularize. At the same time, the shortage of professional and technical talents restricts the promotion and application of disciplinary technologies. In addition, there are regional differences in global industry standards and regulatory norms. Different countries have different requirements for detection processes, reagent certification and quality control, increasing the difficulty of cross-border promotion of technologies and products. Coupled with the safety and ethical controversies of some technologies, the balanced and high-quality development of global immunohematology is further restricted.
This report studies the global Immunohematology demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Immunohematology, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Immunohematology that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Immunohematology total market, 2021-2032, (USD Million)
Global Immunohematology total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Immunohematology total market, key domestic companies, and share, (USD Million)
Global Immunohematology revenue by player, revenue and market share 2021-2026, (USD Million)
Global Immunohematology total market by Type, CAGR, 2021-2032, (USD Million)
Global Immunohematology total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Immunohematology market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bio-Rad Laboratories, Grifols, Immucor (Werfen), QuidelOrtho, Beckman Coulter, DIAGAST, Hemo bioscience, Institut de Biotechnologies Jacques Boy, MTC INVITRO, AliveDx, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Immunohematology market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Immunohematology Market, By Region:
1. How big is the global Immunohematology market?
2. What is the demand of the global Immunohematology market?
3. What is the year over year growth of the global Immunohematology market?
4. What is the total value of the global Immunohematology market?
5. Who are the Major Players in the global Immunohematology market?
6. What are the growth factors driving the market demand?
Commercially, immunohematology usually refers to pre-transfusion compatibility testing and blood-group serology/molecular typing solutions. The core menu includes ABO/Rh typing, antibody screening, antibody identification, crossmatching, DAT/IAT, antigen typing/extended phenotyping, and selected molecular typing for rare or complex cases. Product formats span gel/cards, reagent red cells, antisera, QC materials, fully/semi-automated analyzers, data-management software, and in some cases reference-laboratory testing services. Upstream inputs include antibodies, reagent RBC materials, plastics/consumables, automation modules, and software; midstream is reagent?instrument system integration; downstream customers are primarily hospital transfusion laboratories/blood banks, independent labs, blood centers, and reference labs.
Immunohematology, as a core interdisciplinary field integrating immunology and hematology, focuses on the interaction between blood components and the immune system, covering key areas such as blood grouping, transfusion safety, diagnosis and treatment of autoimmune hematological diseases, and hematopoietic stem cell transplantation matching. It is an important part of the global healthcare system, and its development is closely linked to multiple global trends, including the upgrading of clinical needs, breakthroughs in technological innovation, and the protection of public health security. The continuous growth of global clinical transfusion demand and the continuous improvement of transfusion safety standards are the core driving forces. The demand for safe blood transfusion in various surgeries, chronic diseases and trauma treatment has promoted the transformation of immunohematology technology towards precision and standardization, reducing the risk of transfusion adverse reactions. The clinical diagnosis and treatment needs of hematological tumors, autoimmune hematological diseases and other diseases have promoted the discipline to extend towards precise immunotherapy and personalized diagnosis and treatment, broadening the research and application boundaries. Technological innovation continues to empower the industry. The application of automated detection platforms, molecular typing technologies, AI-assisted interpretation systems and other technologies has improved detection efficiency and accuracy, promoting the discipline to develop in a diversified and cross-integrated direction. The improvement of the global public health system and the enhancement of blood safety awareness have promoted countries to strengthen blood screening, rare blood type bank construction and standardized construction of immunohematology laboratories. At the same time, the upgrading of medical infrastructure in emerging markets has released new growth for the development of the discipline. The global cooperation between leading enterprises and scientific research institutions has accelerated the global popularization of technological achievements.
Despite the continuous development of the global immunohematology field and the increasing clinical value, it still faces many challenges. High-end technologies and core reagent barriers are strict. The core technologies of precise molecular typing, high-end detection equipment and key reagents are monopolized by a few international leading enterprises. Emerging markets and developing countries have insufficient investment in scientific research, making it difficult to achieve technological breakthroughs and independent substitution, resulting in unbalanced distribution of medical resources. There are regional differences in the development of the discipline. Developed countries, relying on mature medical systems and scientific research strength, focus on cutting-edge technology research and development and clinical application, occupying a dominant position in the industry. However, some developing countries, limited by medical resources and professional talents, have insufficient accessibility of immunohematology detection and diagnosis and treatment services. There is a gap between clinical application and technological transformation. Some cutting-edge technologies have high R&D costs and long certification cycles, making it difficult to quickly land and popularize. At the same time, the shortage of professional and technical talents restricts the promotion and application of disciplinary technologies. In addition, there are regional differences in global industry standards and regulatory norms. Different countries have different requirements for detection processes, reagent certification and quality control, increasing the difficulty of cross-border promotion of technologies and products. Coupled with the safety and ethical controversies of some technologies, the balanced and high-quality development of global immunohematology is further restricted.
This report studies the global Immunohematology demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Immunohematology, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Immunohematology that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Immunohematology total market, 2021-2032, (USD Million)
Global Immunohematology total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Immunohematology total market, key domestic companies, and share, (USD Million)
Global Immunohematology revenue by player, revenue and market share 2021-2026, (USD Million)
Global Immunohematology total market by Type, CAGR, 2021-2032, (USD Million)
Global Immunohematology total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Immunohematology market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bio-Rad Laboratories, Grifols, Immucor (Werfen), QuidelOrtho, Beckman Coulter, DIAGAST, Hemo bioscience, Institut de Biotechnologies Jacques Boy, MTC INVITRO, AliveDx, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Immunohematology market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Immunohematology Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Immunohematology Analyzers and Systems
- Immunohematology Reagent
- Hospital Transfusion Department/Blood Bank
- Blood Center/Blood Collection and Supply Institution
- Reference Laboratory/Transplant Center
- Others
- Conventional High Frequency
- High Complexity/High Added Value
- Blood-Related Diseases
- HIV
- Hepatitis
- Bio-Rad Laboratories
- Grifols
- Immucor (Werfen)
- QuidelOrtho
- Beckman Coulter
- DIAGAST
- Hemo bioscience
- Institut de Biotechnologies Jacques Boy
- MTC INVITRO
- AliveDx
- AI KANG
1. How big is the global Immunohematology market?
2. What is the demand of the global Immunohematology market?
3. What is the year over year growth of the global Immunohematology market?
4. What is the total value of the global Immunohematology market?
5. Who are the Major Players in the global Immunohematology market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Immunohematology Introduction
1.2 World Immunohematology Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Immunohematology Total Market by Region (by Headquarter Location)
1.3.1 World Immunohematology Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Immunohematology Revenue (2021-2032)
1.3.3 China Based Company Immunohematology Revenue (2021-2032)
1.3.4 Europe Based Company Immunohematology Revenue (2021-2032)
1.3.5 Japan Based Company Immunohematology Revenue (2021-2032)
1.3.6 South Korea Based Company Immunohematology Revenue (2021-2032)
1.3.7 ASEAN Based Company Immunohematology Revenue (2021-2032)
1.3.8 India Based Company Immunohematology Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Immunohematology Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Immunohematology Consumption Value (2021-2032)
2.2 World Immunohematology Consumption Value by Region
2.2.1 World Immunohematology Consumption Value by Region (2021-2026)
2.2.2 World Immunohematology Consumption Value Forecast by Region (2027-2032)
2.3 United States Immunohematology Consumption Value (2021-2032)
2.4 China Immunohematology Consumption Value (2021-2032)
2.5 Europe Immunohematology Consumption Value (2021-2032)
2.6 Japan Immunohematology Consumption Value (2021-2032)
2.7 South Korea Immunohematology Consumption Value (2021-2032)
2.8 ASEAN Immunohematology Consumption Value (2021-2032)
2.9 India Immunohematology Consumption Value (2021-2032)
3 WORLD IMMUNOHEMATOLOGY COMPANIES COMPETITIVE ANALYSIS
3.1 World Immunohematology Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Immunohematology Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Immunohematology in 2025
3.2.3 Global Concentration Ratios (CR8) for Immunohematology in 2025
3.3 Immunohematology Company Evaluation Quadrant
3.4 Immunohematology Market: Overall Company Footprint Analysis
3.4.1 Immunohematology Market: Region Footprint
3.4.2 Immunohematology Market: Company Product Type Footprint
3.4.3 Immunohematology Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Immunohematology Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Immunohematology Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Immunohematology Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Immunohematology Consumption Value Comparison
4.2.1 United States VS China: Immunohematology Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Immunohematology Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Immunohematology Companies and Market Share, 2021-2026
4.3.1 United States Based Immunohematology Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Immunohematology Revenue, (2021-2026)
4.4 China Based Companies Immunohematology Revenue and Market Share, 2021-2026
4.4.1 China Based Immunohematology Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Immunohematology Revenue, (2021-2026)
4.5 Rest of World Based Immunohematology Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Immunohematology Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Immunohematology Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Immunohematology Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Immunohematology Analyzers and Systems
5.2.2 Immunohematology Reagent
5.3 Market Segment by Type
5.3.1 World Immunohematology Market Size by Type (2021-2026)
5.3.2 World Immunohematology Market Size by Type (2027-2032)
5.3.3 World Immunohematology Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY DOWNSTREAM CUSTOMERS
6.1 World Immunohematology Market Size Overview by Downstream Customers: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Downstream Customers
6.2.1 Hospital Transfusion Department/Blood Bank
6.2.2 Blood Center/Blood Collection and Supply Institution
6.2.3 Reference Laboratory/Transplant Center
6.2.4 Others
6.3 Market Segment by Downstream Customers
6.3.1 World Immunohematology Market Size by Downstream Customers (2021-2026)
6.3.2 World Immunohematology Market Size by Downstream Customers (2027-2032)
6.3.3 World Immunohematology Market Size Market Share by Downstream Customers (2027-2032)
7 MARKET ANALYSIS BY CLINICAL COMPLEXITY
7.1 World Immunohematology Market Size Overview by Clinical Complexity: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Clinical Complexity
7.2.1 Conventional High Frequency
7.2.2 High Complexity/High Added Value
7.3 Market Segment by Clinical Complexity
7.3.1 World Immunohematology Market Size by Clinical Complexity (2021-2026)
7.3.2 World Immunohematology Market Size by Clinical Complexity (2027-2032)
7.3.3 World Immunohematology Market Size Market Share by Clinical Complexity (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Immunohematology Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Blood-Related Diseases
8.2.2 HIV
8.2.3 Hepatitis
8.3 Market Segment by Application
8.3.1 World Immunohematology Market Size by Application (2021-2026)
8.3.2 World Immunohematology Market Size by Application (2027-2032)
8.3.3 World Immunohematology Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Bio-Rad Laboratories
9.1.1 Bio-Rad Laboratories Details
9.1.2 Bio-Rad Laboratories Major Business
9.1.3 Bio-Rad Laboratories Immunohematology Product and Services
9.1.4 Bio-Rad Laboratories Immunohematology Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Bio-Rad Laboratories Recent Developments/Updates
9.1.6 Bio-Rad Laboratories Competitive Strengths & Weaknesses
9.2 Grifols
9.2.1 Grifols Details
9.2.2 Grifols Major Business
9.2.3 Grifols Immunohematology Product and Services
9.2.4 Grifols Immunohematology Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Grifols Recent Developments/Updates
9.2.6 Grifols Competitive Strengths & Weaknesses
9.3 Immucor (Werfen)
9.3.1 Immucor (Werfen) Details
9.3.2 Immucor (Werfen) Major Business
9.3.3 Immucor (Werfen) Immunohematology Product and Services
9.3.4 Immucor (Werfen) Immunohematology Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Immucor (Werfen) Recent Developments/Updates
9.3.6 Immucor (Werfen) Competitive Strengths & Weaknesses
9.4 QuidelOrtho
9.4.1 QuidelOrtho Details
9.4.2 QuidelOrtho Major Business
9.4.3 QuidelOrtho Immunohematology Product and Services
9.4.4 QuidelOrtho Immunohematology Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 QuidelOrtho Recent Developments/Updates
9.4.6 QuidelOrtho Competitive Strengths & Weaknesses
9.5 Beckman Coulter
9.5.1 Beckman Coulter Details
9.5.2 Beckman Coulter Major Business
9.5.3 Beckman Coulter Immunohematology Product and Services
9.5.4 Beckman Coulter Immunohematology Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Beckman Coulter Recent Developments/Updates
9.5.6 Beckman Coulter Competitive Strengths & Weaknesses
9.6 DIAGAST
9.6.1 DIAGAST Details
9.6.2 DIAGAST Major Business
9.6.3 DIAGAST Immunohematology Product and Services
9.6.4 DIAGAST Immunohematology Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 DIAGAST Recent Developments/Updates
9.6.6 DIAGAST Competitive Strengths & Weaknesses
9.7 Hemo bioscience
9.7.1 Hemo bioscience Details
9.7.2 Hemo bioscience Major Business
9.7.3 Hemo bioscience Immunohematology Product and Services
9.7.4 Hemo bioscience Immunohematology Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Hemo bioscience Recent Developments/Updates
9.7.6 Hemo bioscience Competitive Strengths & Weaknesses
9.8 Institut de Biotechnologies Jacques Boy
9.8.1 Institut de Biotechnologies Jacques Boy Details
9.8.2 Institut de Biotechnologies Jacques Boy Major Business
9.8.3 Institut de Biotechnologies Jacques Boy Immunohematology Product and Services
9.8.4 Institut de Biotechnologies Jacques Boy Immunohematology Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Institut de Biotechnologies Jacques Boy Recent Developments/Updates
9.8.6 Institut de Biotechnologies Jacques Boy Competitive Strengths & Weaknesses
9.9 MTC INVITRO
9.9.1 MTC INVITRO Details
9.9.2 MTC INVITRO Major Business
9.9.3 MTC INVITRO Immunohematology Product and Services
9.9.4 MTC INVITRO Immunohematology Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 MTC INVITRO Recent Developments/Updates
9.9.6 MTC INVITRO Competitive Strengths & Weaknesses
9.10 AliveDx
9.10.1 AliveDx Details
9.10.2 AliveDx Major Business
9.10.3 AliveDx Immunohematology Product and Services
9.10.4 AliveDx Immunohematology Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 AliveDx Recent Developments/Updates
9.10.6 AliveDx Competitive Strengths & Weaknesses
9.11 AI KANG
9.11.1 AI KANG Details
9.11.2 AI KANG Major Business
9.11.3 AI KANG Immunohematology Product and Services
9.11.4 AI KANG Immunohematology Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 AI KANG Recent Developments/Updates
9.11.6 AI KANG Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Immunohematology Industry Chain
10.2 Immunohematology Upstream Analysis
10.3 Immunohematology Midstream Analysis
10.4 Immunohematology Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Immunohematology Introduction
1.2 World Immunohematology Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Immunohematology Total Market by Region (by Headquarter Location)
1.3.1 World Immunohematology Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Immunohematology Revenue (2021-2032)
1.3.3 China Based Company Immunohematology Revenue (2021-2032)
1.3.4 Europe Based Company Immunohematology Revenue (2021-2032)
1.3.5 Japan Based Company Immunohematology Revenue (2021-2032)
1.3.6 South Korea Based Company Immunohematology Revenue (2021-2032)
1.3.7 ASEAN Based Company Immunohematology Revenue (2021-2032)
1.3.8 India Based Company Immunohematology Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Immunohematology Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Immunohematology Consumption Value (2021-2032)
2.2 World Immunohematology Consumption Value by Region
2.2.1 World Immunohematology Consumption Value by Region (2021-2026)
2.2.2 World Immunohematology Consumption Value Forecast by Region (2027-2032)
2.3 United States Immunohematology Consumption Value (2021-2032)
2.4 China Immunohematology Consumption Value (2021-2032)
2.5 Europe Immunohematology Consumption Value (2021-2032)
2.6 Japan Immunohematology Consumption Value (2021-2032)
2.7 South Korea Immunohematology Consumption Value (2021-2032)
2.8 ASEAN Immunohematology Consumption Value (2021-2032)
2.9 India Immunohematology Consumption Value (2021-2032)
3 WORLD IMMUNOHEMATOLOGY COMPANIES COMPETITIVE ANALYSIS
3.1 World Immunohematology Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Immunohematology Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Immunohematology in 2025
3.2.3 Global Concentration Ratios (CR8) for Immunohematology in 2025
3.3 Immunohematology Company Evaluation Quadrant
3.4 Immunohematology Market: Overall Company Footprint Analysis
3.4.1 Immunohematology Market: Region Footprint
3.4.2 Immunohematology Market: Company Product Type Footprint
3.4.3 Immunohematology Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Immunohematology Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Immunohematology Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Immunohematology Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Immunohematology Consumption Value Comparison
4.2.1 United States VS China: Immunohematology Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Immunohematology Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Immunohematology Companies and Market Share, 2021-2026
4.3.1 United States Based Immunohematology Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Immunohematology Revenue, (2021-2026)
4.4 China Based Companies Immunohematology Revenue and Market Share, 2021-2026
4.4.1 China Based Immunohematology Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Immunohematology Revenue, (2021-2026)
4.5 Rest of World Based Immunohematology Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Immunohematology Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Immunohematology Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Immunohematology Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Immunohematology Analyzers and Systems
5.2.2 Immunohematology Reagent
5.3 Market Segment by Type
5.3.1 World Immunohematology Market Size by Type (2021-2026)
5.3.2 World Immunohematology Market Size by Type (2027-2032)
5.3.3 World Immunohematology Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY DOWNSTREAM CUSTOMERS
6.1 World Immunohematology Market Size Overview by Downstream Customers: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Downstream Customers
6.2.1 Hospital Transfusion Department/Blood Bank
6.2.2 Blood Center/Blood Collection and Supply Institution
6.2.3 Reference Laboratory/Transplant Center
6.2.4 Others
6.3 Market Segment by Downstream Customers
6.3.1 World Immunohematology Market Size by Downstream Customers (2021-2026)
6.3.2 World Immunohematology Market Size by Downstream Customers (2027-2032)
6.3.3 World Immunohematology Market Size Market Share by Downstream Customers (2027-2032)
7 MARKET ANALYSIS BY CLINICAL COMPLEXITY
7.1 World Immunohematology Market Size Overview by Clinical Complexity: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Clinical Complexity
7.2.1 Conventional High Frequency
7.2.2 High Complexity/High Added Value
7.3 Market Segment by Clinical Complexity
7.3.1 World Immunohematology Market Size by Clinical Complexity (2021-2026)
7.3.2 World Immunohematology Market Size by Clinical Complexity (2027-2032)
7.3.3 World Immunohematology Market Size Market Share by Clinical Complexity (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Immunohematology Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Blood-Related Diseases
8.2.2 HIV
8.2.3 Hepatitis
8.3 Market Segment by Application
8.3.1 World Immunohematology Market Size by Application (2021-2026)
8.3.2 World Immunohematology Market Size by Application (2027-2032)
8.3.3 World Immunohematology Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Bio-Rad Laboratories
9.1.1 Bio-Rad Laboratories Details
9.1.2 Bio-Rad Laboratories Major Business
9.1.3 Bio-Rad Laboratories Immunohematology Product and Services
9.1.4 Bio-Rad Laboratories Immunohematology Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Bio-Rad Laboratories Recent Developments/Updates
9.1.6 Bio-Rad Laboratories Competitive Strengths & Weaknesses
9.2 Grifols
9.2.1 Grifols Details
9.2.2 Grifols Major Business
9.2.3 Grifols Immunohematology Product and Services
9.2.4 Grifols Immunohematology Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Grifols Recent Developments/Updates
9.2.6 Grifols Competitive Strengths & Weaknesses
9.3 Immucor (Werfen)
9.3.1 Immucor (Werfen) Details
9.3.2 Immucor (Werfen) Major Business
9.3.3 Immucor (Werfen) Immunohematology Product and Services
9.3.4 Immucor (Werfen) Immunohematology Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Immucor (Werfen) Recent Developments/Updates
9.3.6 Immucor (Werfen) Competitive Strengths & Weaknesses
9.4 QuidelOrtho
9.4.1 QuidelOrtho Details
9.4.2 QuidelOrtho Major Business
9.4.3 QuidelOrtho Immunohematology Product and Services
9.4.4 QuidelOrtho Immunohematology Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 QuidelOrtho Recent Developments/Updates
9.4.6 QuidelOrtho Competitive Strengths & Weaknesses
9.5 Beckman Coulter
9.5.1 Beckman Coulter Details
9.5.2 Beckman Coulter Major Business
9.5.3 Beckman Coulter Immunohematology Product and Services
9.5.4 Beckman Coulter Immunohematology Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Beckman Coulter Recent Developments/Updates
9.5.6 Beckman Coulter Competitive Strengths & Weaknesses
9.6 DIAGAST
9.6.1 DIAGAST Details
9.6.2 DIAGAST Major Business
9.6.3 DIAGAST Immunohematology Product and Services
9.6.4 DIAGAST Immunohematology Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 DIAGAST Recent Developments/Updates
9.6.6 DIAGAST Competitive Strengths & Weaknesses
9.7 Hemo bioscience
9.7.1 Hemo bioscience Details
9.7.2 Hemo bioscience Major Business
9.7.3 Hemo bioscience Immunohematology Product and Services
9.7.4 Hemo bioscience Immunohematology Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Hemo bioscience Recent Developments/Updates
9.7.6 Hemo bioscience Competitive Strengths & Weaknesses
9.8 Institut de Biotechnologies Jacques Boy
9.8.1 Institut de Biotechnologies Jacques Boy Details
9.8.2 Institut de Biotechnologies Jacques Boy Major Business
9.8.3 Institut de Biotechnologies Jacques Boy Immunohematology Product and Services
9.8.4 Institut de Biotechnologies Jacques Boy Immunohematology Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Institut de Biotechnologies Jacques Boy Recent Developments/Updates
9.8.6 Institut de Biotechnologies Jacques Boy Competitive Strengths & Weaknesses
9.9 MTC INVITRO
9.9.1 MTC INVITRO Details
9.9.2 MTC INVITRO Major Business
9.9.3 MTC INVITRO Immunohematology Product and Services
9.9.4 MTC INVITRO Immunohematology Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 MTC INVITRO Recent Developments/Updates
9.9.6 MTC INVITRO Competitive Strengths & Weaknesses
9.10 AliveDx
9.10.1 AliveDx Details
9.10.2 AliveDx Major Business
9.10.3 AliveDx Immunohematology Product and Services
9.10.4 AliveDx Immunohematology Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 AliveDx Recent Developments/Updates
9.10.6 AliveDx Competitive Strengths & Weaknesses
9.11 AI KANG
9.11.1 AI KANG Details
9.11.2 AI KANG Major Business
9.11.3 AI KANG Immunohematology Product and Services
9.11.4 AI KANG Immunohematology Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 AI KANG Recent Developments/Updates
9.11.6 AI KANG Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Immunohematology Industry Chain
10.2 Immunohematology Upstream Analysis
10.3 Immunohematology Midstream Analysis
10.4 Immunohematology Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Immunohematology Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Immunohematology Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Immunohematology Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Immunohematology Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Immunohematology Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Immunohematology Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Immunohematology Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Immunohematology Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Immunohematology Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Immunohematology Players in 2025
Table 12. World Immunohematology Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Immunohematology Company Evaluation Quadrant
Table 14. Head Office of Key Immunohematology Players
Table 15. Immunohematology Market: Company Product Type Footprint
Table 16. Immunohematology Market: Company Product Application Footprint
Table 17. Immunohematology Mergers & Acquisitions Activity
Table 18. United States VS China Immunohematology Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Immunohematology Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Immunohematology Companies, Headquarters (States, Country)
Table 21. United States Based Companies Immunohematology Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Immunohematology Revenue Market Share (2021-2026)
Table 23. China Based Immunohematology Companies, Headquarters (Province, Country)
Table 24. China Based Companies Immunohematology Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Immunohematology Revenue Market Share (2021-2026)
Table 26. Rest of World Based Immunohematology Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Immunohematology Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Immunohematology Revenue Market Share (2021-2026)
Table 29. World Immunohematology Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Immunohematology Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Immunohematology Market Size by Type (2027-2032) & (USD Million)
Table 32. World Immunohematology Market Size by Downstream Customers, (USD Million), 2021 & 2025 & 2032
Table 33. World Immunohematology Market Size Value by Downstream Customers (2021-2026) & (USD Million)
Table 34. World Immunohematology Market Size by Downstream Customers (2027-2032) & (USD Million)
Table 35. World Immunohematology Market Size by Clinical Complexity, (USD Million), 2021 & 2025 & 2032
Table 36. World Immunohematology Market Size Value by Clinical Complexity (2021-2026) & (USD Million)
Table 37. World Immunohematology Market Size by Clinical Complexity (2027-2032) & (USD Million)
Table 38. World Immunohematology Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Immunohematology Market Size by Application (2021-2026) & (USD Million)
Table 40. World Immunohematology Market Size by Application (2027-2032) & (USD Million)
Table 41. Bio-Rad Laboratories Basic Information, Manufacturing Base and Competitors
Table 42. Bio-Rad Laboratories Major Business
Table 43. Bio-Rad Laboratories Immunohematology Product and Services
Table 44. Bio-Rad Laboratories Immunohematology Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Bio-Rad Laboratories Recent Developments/Updates
Table 46. Bio-Rad Laboratories Competitive Strengths & Weaknesses
Table 47. Grifols Basic Information, Manufacturing Base and Competitors
Table 48. Grifols Major Business
Table 49. Grifols Immunohematology Product and Services
Table 50. Grifols Immunohematology Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Grifols Recent Developments/Updates
Table 52. Grifols Competitive Strengths & Weaknesses
Table 53. Immucor (Werfen) Basic Information, Manufacturing Base and Competitors
Table 54. Immucor (Werfen) Major Business
Table 55. Immucor (Werfen) Immunohematology Product and Services
Table 56. Immucor (Werfen) Immunohematology Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Immucor (Werfen) Recent Developments/Updates
Table 58. Immucor (Werfen) Competitive Strengths & Weaknesses
Table 59. QuidelOrtho Basic Information, Manufacturing Base and Competitors
Table 60. QuidelOrtho Major Business
Table 61. QuidelOrtho Immunohematology Product and Services
Table 62. QuidelOrtho Immunohematology Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. QuidelOrtho Recent Developments/Updates
Table 64. QuidelOrtho Competitive Strengths & Weaknesses
Table 65. Beckman Coulter Basic Information, Manufacturing Base and Competitors
Table 66. Beckman Coulter Major Business
Table 67. Beckman Coulter Immunohematology Product and Services
Table 68. Beckman Coulter Immunohematology Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Beckman Coulter Recent Developments/Updates
Table 70. Beckman Coulter Competitive Strengths & Weaknesses
Table 71. DIAGAST Basic Information, Manufacturing Base and Competitors
Table 72. DIAGAST Major Business
Table 73. DIAGAST Immunohematology Product and Services
Table 74. DIAGAST Immunohematology Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. DIAGAST Recent Developments/Updates
Table 76. DIAGAST Competitive Strengths & Weaknesses
Table 77. Hemo bioscience Basic Information, Manufacturing Base and Competitors
Table 78. Hemo bioscience Major Business
Table 79. Hemo bioscience Immunohematology Product and Services
Table 80. Hemo bioscience Immunohematology Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Hemo bioscience Recent Developments/Updates
Table 82. Hemo bioscience Competitive Strengths & Weaknesses
Table 83. Institut de Biotechnologies Jacques Boy Basic Information, Manufacturing Base and Competitors
Table 84. Institut de Biotechnologies Jacques Boy Major Business
Table 85. Institut de Biotechnologies Jacques Boy Immunohematology Product and Services
Table 86. Institut de Biotechnologies Jacques Boy Immunohematology Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Institut de Biotechnologies Jacques Boy Recent Developments/Updates
Table 88. Institut de Biotechnologies Jacques Boy Competitive Strengths & Weaknesses
Table 89. MTC INVITRO Basic Information, Manufacturing Base and Competitors
Table 90. MTC INVITRO Major Business
Table 91. MTC INVITRO Immunohematology Product and Services
Table 92. MTC INVITRO Immunohematology Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. MTC INVITRO Recent Developments/Updates
Table 94. MTC INVITRO Competitive Strengths & Weaknesses
Table 95. AliveDx Basic Information, Manufacturing Base and Competitors
Table 96. AliveDx Major Business
Table 97. AliveDx Immunohematology Product and Services
Table 98. AliveDx Immunohematology Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. AliveDx Recent Developments/Updates
Table 100. AliveDx Competitive Strengths & Weaknesses
Table 101. AI KANG Basic Information, Manufacturing Base and Competitors
Table 102. AI KANG Major Business
Table 103. AI KANG Immunohematology Product and Services
Table 104. AI KANG Immunohematology Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. AI KANG Recent Developments/Updates
Table 106. AI KANG Competitive Strengths & Weaknesses
Table 107. Global Key Players of Immunohematology Upstream (Raw Materials)
Table 108. Global Immunohematology Typical Customers
Table 1. World Immunohematology Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Immunohematology Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Immunohematology Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Immunohematology Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Immunohematology Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Immunohematology Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Immunohematology Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Immunohematology Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Immunohematology Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Immunohematology Players in 2025
Table 12. World Immunohematology Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Immunohematology Company Evaluation Quadrant
Table 14. Head Office of Key Immunohematology Players
Table 15. Immunohematology Market: Company Product Type Footprint
Table 16. Immunohematology Market: Company Product Application Footprint
Table 17. Immunohematology Mergers & Acquisitions Activity
Table 18. United States VS China Immunohematology Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Immunohematology Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Immunohematology Companies, Headquarters (States, Country)
Table 21. United States Based Companies Immunohematology Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Immunohematology Revenue Market Share (2021-2026)
Table 23. China Based Immunohematology Companies, Headquarters (Province, Country)
Table 24. China Based Companies Immunohematology Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Immunohematology Revenue Market Share (2021-2026)
Table 26. Rest of World Based Immunohematology Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Immunohematology Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Immunohematology Revenue Market Share (2021-2026)
Table 29. World Immunohematology Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Immunohematology Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Immunohematology Market Size by Type (2027-2032) & (USD Million)
Table 32. World Immunohematology Market Size by Downstream Customers, (USD Million), 2021 & 2025 & 2032
Table 33. World Immunohematology Market Size Value by Downstream Customers (2021-2026) & (USD Million)
Table 34. World Immunohematology Market Size by Downstream Customers (2027-2032) & (USD Million)
Table 35. World Immunohematology Market Size by Clinical Complexity, (USD Million), 2021 & 2025 & 2032
Table 36. World Immunohematology Market Size Value by Clinical Complexity (2021-2026) & (USD Million)
Table 37. World Immunohematology Market Size by Clinical Complexity (2027-2032) & (USD Million)
Table 38. World Immunohematology Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Immunohematology Market Size by Application (2021-2026) & (USD Million)
Table 40. World Immunohematology Market Size by Application (2027-2032) & (USD Million)
Table 41. Bio-Rad Laboratories Basic Information, Manufacturing Base and Competitors
Table 42. Bio-Rad Laboratories Major Business
Table 43. Bio-Rad Laboratories Immunohematology Product and Services
Table 44. Bio-Rad Laboratories Immunohematology Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Bio-Rad Laboratories Recent Developments/Updates
Table 46. Bio-Rad Laboratories Competitive Strengths & Weaknesses
Table 47. Grifols Basic Information, Manufacturing Base and Competitors
Table 48. Grifols Major Business
Table 49. Grifols Immunohematology Product and Services
Table 50. Grifols Immunohematology Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Grifols Recent Developments/Updates
Table 52. Grifols Competitive Strengths & Weaknesses
Table 53. Immucor (Werfen) Basic Information, Manufacturing Base and Competitors
Table 54. Immucor (Werfen) Major Business
Table 55. Immucor (Werfen) Immunohematology Product and Services
Table 56. Immucor (Werfen) Immunohematology Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Immucor (Werfen) Recent Developments/Updates
Table 58. Immucor (Werfen) Competitive Strengths & Weaknesses
Table 59. QuidelOrtho Basic Information, Manufacturing Base and Competitors
Table 60. QuidelOrtho Major Business
Table 61. QuidelOrtho Immunohematology Product and Services
Table 62. QuidelOrtho Immunohematology Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. QuidelOrtho Recent Developments/Updates
Table 64. QuidelOrtho Competitive Strengths & Weaknesses
Table 65. Beckman Coulter Basic Information, Manufacturing Base and Competitors
Table 66. Beckman Coulter Major Business
Table 67. Beckman Coulter Immunohematology Product and Services
Table 68. Beckman Coulter Immunohematology Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Beckman Coulter Recent Developments/Updates
Table 70. Beckman Coulter Competitive Strengths & Weaknesses
Table 71. DIAGAST Basic Information, Manufacturing Base and Competitors
Table 72. DIAGAST Major Business
Table 73. DIAGAST Immunohematology Product and Services
Table 74. DIAGAST Immunohematology Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. DIAGAST Recent Developments/Updates
Table 76. DIAGAST Competitive Strengths & Weaknesses
Table 77. Hemo bioscience Basic Information, Manufacturing Base and Competitors
Table 78. Hemo bioscience Major Business
Table 79. Hemo bioscience Immunohematology Product and Services
Table 80. Hemo bioscience Immunohematology Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Hemo bioscience Recent Developments/Updates
Table 82. Hemo bioscience Competitive Strengths & Weaknesses
Table 83. Institut de Biotechnologies Jacques Boy Basic Information, Manufacturing Base and Competitors
Table 84. Institut de Biotechnologies Jacques Boy Major Business
Table 85. Institut de Biotechnologies Jacques Boy Immunohematology Product and Services
Table 86. Institut de Biotechnologies Jacques Boy Immunohematology Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Institut de Biotechnologies Jacques Boy Recent Developments/Updates
Table 88. Institut de Biotechnologies Jacques Boy Competitive Strengths & Weaknesses
Table 89. MTC INVITRO Basic Information, Manufacturing Base and Competitors
Table 90. MTC INVITRO Major Business
Table 91. MTC INVITRO Immunohematology Product and Services
Table 92. MTC INVITRO Immunohematology Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. MTC INVITRO Recent Developments/Updates
Table 94. MTC INVITRO Competitive Strengths & Weaknesses
Table 95. AliveDx Basic Information, Manufacturing Base and Competitors
Table 96. AliveDx Major Business
Table 97. AliveDx Immunohematology Product and Services
Table 98. AliveDx Immunohematology Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. AliveDx Recent Developments/Updates
Table 100. AliveDx Competitive Strengths & Weaknesses
Table 101. AI KANG Basic Information, Manufacturing Base and Competitors
Table 102. AI KANG Major Business
Table 103. AI KANG Immunohematology Product and Services
Table 104. AI KANG Immunohematology Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. AI KANG Recent Developments/Updates
Table 106. AI KANG Competitive Strengths & Weaknesses
Table 107. Global Key Players of Immunohematology Upstream (Raw Materials)
Table 108. Global Immunohematology Typical Customers
LIST OF FIGURES
Figure 1. Immunohematology Picture
Figure 2. World Immunohematology Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Immunohematology Total Revenue (2021-2032) & (USD Million)
Figure 4. World Immunohematology Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Immunohematology Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Immunohematology Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Immunohematology Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Immunohematology Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Immunohematology Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Immunohematology Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Immunohematology Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Immunohematology Revenue (2021-2032) & (USD Million)
Figure 13. Immunohematology Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Immunohematology Consumption Value (2021-2032) & (USD Million)
Figure 16. World Immunohematology Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Immunohematology Consumption Value (2021-2032) & (USD Million)
Figure 18. China Immunohematology Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Immunohematology Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Immunohematology Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Immunohematology Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Immunohematology Consumption Value (2021-2032) & (USD Million)
Figure 23. India Immunohematology Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Immunohematology by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Immunohematology Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Immunohematology Markets in 2025
Figure 27. United States VS China: Immunohematology Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Immunohematology Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Immunohematology Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Immunohematology Market Size Market Share by Type in 2025
Figure 31. Immunohematology Analyzers and Systems
Figure 32. Immunohematology Reagent
Figure 33. World Immunohematology Market Size Market Share by Type (2021-2032)
Figure 34. World Immunohematology Market Size by Downstream Customers, (USD Million), 2021 & 2025 & 2032
Figure 35. World Immunohematology Market Size Market Share by Downstream Customers in 2025
Figure 36. Hospital Transfusion Department/Blood Bank
Figure 37. Blood Center/Blood Collection and Supply Institution
Figure 38. Reference Laboratory/Transplant Center
Figure 39. Others
Figure 40. World Immunohematology Market Size Market Share by Downstream Customers (2021-2032)
Figure 41. World Immunohematology Market Size by Clinical Complexity, (USD Million), 2021 & 2025 & 2032
Figure 42. World Immunohematology Market Size Market Share by Clinical Complexity in 2025
Figure 43. Conventional High Frequency
Figure 44. High Complexity/High Added Value
Figure 45. World Immunohematology Market Size Market Share by Clinical Complexity (2021-2032)
Figure 46. World Immunohematology Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 47. World Immunohematology Market Size Market Share by Application in 2025
Figure 48. Blood-Related Diseases
Figure 49. HIV
Figure 50. Hepatitis
Figure 51. World Immunohematology Market Size Market Share by Application (2021-2032)
Figure 52. Immunohematology Industrial Chain
Figure 53. Methodology
Figure 54. Research Process and Data Source
Figure 1. Immunohematology Picture
Figure 2. World Immunohematology Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Immunohematology Total Revenue (2021-2032) & (USD Million)
Figure 4. World Immunohematology Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Immunohematology Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Immunohematology Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Immunohematology Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Immunohematology Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Immunohematology Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Immunohematology Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Immunohematology Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Immunohematology Revenue (2021-2032) & (USD Million)
Figure 13. Immunohematology Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Immunohematology Consumption Value (2021-2032) & (USD Million)
Figure 16. World Immunohematology Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Immunohematology Consumption Value (2021-2032) & (USD Million)
Figure 18. China Immunohematology Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Immunohematology Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Immunohematology Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Immunohematology Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Immunohematology Consumption Value (2021-2032) & (USD Million)
Figure 23. India Immunohematology Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Immunohematology by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Immunohematology Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Immunohematology Markets in 2025
Figure 27. United States VS China: Immunohematology Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Immunohematology Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Immunohematology Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Immunohematology Market Size Market Share by Type in 2025
Figure 31. Immunohematology Analyzers and Systems
Figure 32. Immunohematology Reagent
Figure 33. World Immunohematology Market Size Market Share by Type (2021-2032)
Figure 34. World Immunohematology Market Size by Downstream Customers, (USD Million), 2021 & 2025 & 2032
Figure 35. World Immunohematology Market Size Market Share by Downstream Customers in 2025
Figure 36. Hospital Transfusion Department/Blood Bank
Figure 37. Blood Center/Blood Collection and Supply Institution
Figure 38. Reference Laboratory/Transplant Center
Figure 39. Others
Figure 40. World Immunohematology Market Size Market Share by Downstream Customers (2021-2032)
Figure 41. World Immunohematology Market Size by Clinical Complexity, (USD Million), 2021 & 2025 & 2032
Figure 42. World Immunohematology Market Size Market Share by Clinical Complexity in 2025
Figure 43. Conventional High Frequency
Figure 44. High Complexity/High Added Value
Figure 45. World Immunohematology Market Size Market Share by Clinical Complexity (2021-2032)
Figure 46. World Immunohematology Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 47. World Immunohematology Market Size Market Share by Application in 2025
Figure 48. Blood-Related Diseases
Figure 49. HIV
Figure 50. Hepatitis
Figure 51. World Immunohematology Market Size Market Share by Application (2021-2032)
Figure 52. Immunohematology Industrial Chain
Figure 53. Methodology
Figure 54. Research Process and Data Source
